The effects of insulin-like growth factors on tumorigenesis and neoplastic growth.
about
Role of insulin-like growth factor binding protein-4 in prevention of colon cancerNKX3.1 activates expression of insulin-like growth factor binding protein-3 to mediate insulin-like growth factor-I signaling and cell proliferationComprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortiumControversies in the definition and treatment of idiopathic short stature (ISS)Inhibition of insulin-like growth factor-1 receptor signaling enhances growth-inhibitory and proapoptotic effects of gefitinib (Iressa) in human breast cancer cellsChanges in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersIs there an effect of ghrelin/ghrelin analogs on cancer? A systematic reviewCurrent perspectives between metabolic syndrome and cancerDietary fat intake and ovarian cancer risk: a meta-analysis of epidemiological studiesObesity and cancer: at the crossroads of cellular metabolism and proliferationThe interaction of insulin-like growth factor-I with the N-terminal domain of IGFBP-5Association between insulin-like growth factor-binding protein-3 polymorphism-202 A/C and the risk of prostate cancer: a meta-analysisObesity, insulin resistance and cancer riskRole of insulin-like growth factor binding protein-3 in breast cancer cell growthCirculating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohortsRegulation of IGF-I function by proinflammatory cytokines: at the interface of immunology and endocrinologyInteractions among genetic variants in apoptosis pathway genes, reflux symptoms, body mass index, and smoking indicate two distinct etiologic patterns of esophageal adenocarcinomaPotentiating the efficacy of molecular targeted therapy for hepatocellular carcinoma by inhibiting the insulin-like growth factor pathwayGenetic variation in insulin-like growth factors and brain tumor risk.Favorable prognostic value of SOCS2 and IGF-I in breast cancer.[Growth hormone treatment inTurner syndrome: data and reflections].Reversal of oncogene transformation and suppression of tumor growth by the novel IGF1R kinase inhibitor A-928605.Insulin-like growth factor I controls adhesion strength mediated by alpha5beta1 integrins in motile carcinoma cells.Subtype of dietary fat in relation to risk of Hodgkin lymphoma: a population-based case-control study in Connecticut and Massachusetts.Supervised Clustering of Adipokines and Hormonal Receptors Predict Prognosis in a Population of Obese Women with Type 1 Endometrial Cancer.Plasma insulin-like growth factors, insulin-like binding protein-3, and outcome in metastatic colorectal cancer: results from intergroup trial N9741.A hepatoprotective Lindera obtusiloba extract suppresses growth and attenuates insulin like growth factor-1 receptor signaling and NF-kappaB activity in human liver cancer cell lines.Effective treatment of experimental human non-Hodgkin's lymphomas with antagonists of growth hormone-releasing hormoneThe IGF axis and hepatocarcinogenesis.Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy.Targeting insulin-like growth factor axis in hepatocellular carcinoma.Induction of apoptosis by a peptide from Porphyra yezoensis: regulation of the insulin-like growth factor I receptor signaling pathway in MCF-7 cells.Cancer, physical activity, and exerciseSpecific metabolic biomarkers as risk and prognostic factors in colorectal cancer.The Association between Polymorphismsin Insulin and Obesity Related Genesand Risk of Colorectal Cancer.Pediatric brain tumor treatment: growth consequences and their managementTumor suppressor BRCA1 is expressed in prostate cancer and controls insulin-like growth factor I receptor (IGF-IR) gene transcription in an androgen receptor-dependent manner.Insulin-like growth factor 1 receptor and response to anti-IGF1R antibody therapy in osteosarcoma.Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trialAssociations of diabetes mellitus with site-specific cancer mortality in the Asia-Pacific region
P2860
Q21245590-BD4340B2-6780-4B96-9394-BE56A46C3D39Q24317081-C01C097B-F870-4B77-80DE-EC067071C65FQ24614574-562EDF17-9880-434C-A38F-63D33B658C27Q24626074-09E079CF-D971-4E33-B19D-6C7CF70F01ADQ24810622-171ECBD0-0C7F-4DA8-B8FB-7EBA42A5A649Q24813705-16856E15-378B-40BC-8CE3-7E7D7CCA7B22Q26739709-CC116F43-F09B-42CF-A76C-5C2247D1E97FQ26749299-ACB9DC90-6814-471B-BDC1-F771468F163FQ26749395-9F030CB6-84FA-44D2-BEAF-6DC91C31C86AQ27003989-A4106ACE-5FBA-491C-8893-83E728601777Q27633115-371AC9F5-00CB-4115-9772-044E487DFE55Q28077769-80CBB96A-A60D-4F7A-AD09-26515448AAACQ28189539-F054A101-8A24-4CBE-BB99-63AC5BCF12E7Q28202893-BC307A33-9CC7-46C7-BCCE-4B08E548CFC9Q28211600-2D3B1876-BCCD-48DA-B88D-14B9266AF7A7Q28386983-4BB272FD-A474-488F-A524-52FFF1E41146Q28396031-DB506FE4-E3E5-40BB-9B46-D40BAAE385BCQ28534009-93F6E8B8-6FBF-4941-9693-700E6C4DA318Q30487836-4F8EAD33-CA64-4EC2-B542-7F0B9D3EFBC3Q33291671-1704F90C-1C2F-463F-BDF7-EB2A12C20AA0Q33370093-51FC7380-2F5F-4706-BBC1-7FE5C7130556Q33500359-FFB3C96C-2B95-4C90-BE1C-6113E2817563Q33564187-34554AF4-5ADA-46BA-907C-FB1A2B46BBC7Q33709207-FEFA7830-8853-4433-97F4-6049F42D4161Q33755309-CAA7640F-82CF-4330-8405-E4AEDE1A8232Q33791812-067DD6A0-7EB0-4EF1-AB35-96A20D118971Q33898852-C06C9CD7-9FBF-4ABE-A153-BB7960CD5F8EQ33906715-E547DCAD-4748-45CA-96FC-2E2E66160DFBQ33918694-BFA27AD9-7405-4CCE-BE17-A216021BB7EAQ33934670-688C0EC4-9314-4EB0-92E8-83032DE156D4Q33951057-6907B4E3-8DCA-488A-B37A-E9B853082D61Q34000644-F6388CAF-1D2A-4ED0-8CF1-594CAD9DAB81Q34004946-99110080-95D0-45BE-8DBC-27D6A43DD945Q34008787-463DC31A-47F1-47F1-9268-BD3CABCADBCAQ34082468-791390AF-18B5-40FB-A158-E8A732686A33Q34106670-E7FD4D3C-03F4-45F8-99D7-A94A6686CA2BQ34109373-F840FAF8-3270-4603-AF84-9F236FA2AE9BQ34110523-982254C0-4E44-445E-A272-9BC04F757C3CQ34115984-6761FE23-CF2A-4D5C-8B73-248AB7D35C22Q34222524-8C93443D-1659-44BF-AFB3-E8545C458CFC
P2860
The effects of insulin-like growth factors on tumorigenesis and neoplastic growth.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The effects of insulin-like growth factors on tumorigenesis and neoplastic growth.
@ast
The effects of insulin-like growth factors on tumorigenesis and neoplastic growth.
@en
type
label
The effects of insulin-like growth factors on tumorigenesis and neoplastic growth.
@ast
The effects of insulin-like growth factors on tumorigenesis and neoplastic growth.
@en
prefLabel
The effects of insulin-like growth factors on tumorigenesis and neoplastic growth.
@ast
The effects of insulin-like growth factors on tumorigenesis and neoplastic growth.
@en
P2093
P356
P1433
P1476
The effects of insulin-like growth factors on tumorigenesis and neoplastic growth.
@en
P2093
Flyvbjerg A
Khandwala HM
McCutcheon IE
P304
P356
10.1210/EDRV.21.3.0399
P577
2000-06-01T00:00:00Z